University of Wisconsin
School of Medicine and Public Health

Monoclonal Antibody Treatments for Alzheimer's Disease: the Good, the Bad, and the Difficult

Robert Przybelski, MD, MS, FAAFP

Division of Geriatrics and Gerontology
UW School of Medicine and Public Health
Robert Przybelski, MD, MS, FAACP